Cerenome, Inc: H.C. Wainwright raises target price to $7 from $1
CNSY•H.C. Wainwright raised its target price for Cerenome, Inc to $7 from $1.
Related News

Summit Therapeutics launches Phase III ivonescimab trial in Stage III lung cancer
SMMT•

Ducommun CFO participates in Goldman Sachs Industrials and Materials Conference
DCO•

Nasdaq could deepen its slide but small ray of hope
QQQ•

Bridger Aerospace Group Holdings: Stifel cuts to hold from buy and target price to $0.25 from $2.1
BAER•

CIBC sets final terms for up to GBP 1 million preference share-linked note offering
CM•